Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  C4X Discovery Holdings PLC    C4XD   GB00BQQ2RV18

C4X DISCOVERY HOLDINGS PLC

(C4XD)
  Report  
Delayed Quote. Delayed London Stock Exchange - 07/23 11:35:22 am
47 GBp   -2.08%
01/15C4X DISCOVERY : Result of AGM
PU
2018C4X DISCOVERY : C4XD and Horizon Discovery enter exclusive partnership
PU
2018C4X DISCOVERY : partnership with Horizon Discovery
PU
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/17/2019 07/18/2019 07/19/2019 07/22/2019 07/23/2019 Date
49.5(c) 49.5(c) 48(c) 48(c) 47 Last
3 750 7 426 81 020 5 434 18 887 Volume
0.00% 0.00% -3.03% 0.00% -2.08% Change
More quotes
Financials (GBP)
Sales 2019 -
EBIT 2019 -13,8 M
Net income 2019 -
Finance 2019 3,20 M
Yield 2019 29,8%
Sales 2020 -
EBIT 2020 -14,9 M
Net income 2020 -
Debt 2020 9,00 M
Yield 2020 36,2%
P/E ratio 2019 -
P/E ratio 2020 -
EV / Sales2019 infx
EV / Sales2020 infx
Capitalization 27,2 M
More Financials
Company
C4X Discovery Holdings plc is a drug discovery and development company. The Company is engaged in the provision of technologies to improve the drug discovery process for small molecule therapies. Its discovery portfolio targets addiction, diabetes, inflammatory diseases and oncology, and includes... 
More about the company
Latest news on C4X DISCOVERY HOLDINGS PLC
01/15C4X DISCOVERY : Result of AGM
PU
2018C4X DISCOVERY : C4XD and Horizon Discovery enter exclusive partnership
PU
2018C4X DISCOVERY : partnership with Horizon Discovery
PU
2018C4X DISCOVERY : 2018 Annual Report
PU
2018C4X DISCOVERY : collaboration with E-Therapeutics identifies new pathophysiologi..
PU
2018C4X DISCOVERY : C4XD enters discovery partnership with state-of-the-art artifici..
PU
2018C4X DISCOVERY : Discovery partnership with GTN Ltd.
PU
2018C4X DISCOVERY : LifeArc and C4X Discovery join forces to develop small molecule ..
PU
2018C4X DISCOVERY : Discovery partnership with LifeArc
PU
2018C4X DISCOVERY : Full year results for the year ended 31 July 2018
PU
More news
Analyst Recommendations on C4X DISCOVERY HOLDINGS PLC
More recommendations
Sector news : Biotechnology & Medical Research - NEC
05:11pGILEAD SCIENCES : Releases Data From HIV Cure Research Program on Vesatolimod, G..
DJ
07/22GILEAD SCIENCES : Says Study of GS-6207 Showed HIV Capsid Inhibition Can Lead Vi..
DJ
07/22GILEAD SCIENCES : Licenses Durect's Saber Technology for Injectable HIV Product
DJ
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart C4X DISCOVERY HOLDINGS PLC
Duration : Period :
C4X Discovery Holdings PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends C4X DISCOVERY HOLDINGS PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 124,00  GBp
Last Close Price 0,47  GBp
Spread / Highest target 26 283%
Spread / Average Target 26 283%
Spread / Lowest Target 26 283%
EPS Revisions
Managers
NameTitle
Clive James Dix Chief Executive Officer & Executive Director
Eva-Lotta Allan Non-Executive Chairman
Bradley Richard Hoy Chief Financial Officer & Executive Director
Craig Fox Chief Scientific Officer & Executive Director
Alexander James Stevenson Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
C4X DISCOVERY HOLDINGS PLC-28.89%35
IQVIA HOLDINGS INC34.52%30 823
LONZA GROUP33.10%25 850
CELLTRION, INC.--.--%20 040
INCYTE CORPORATION28.50%17 522
EXACT SCIENCES CORPORATION82.06%14 987